ArticleClinical cancer research : an official journal of the American Association for Cancer Research2011

NEMO-binding domain peptide inhibits constitutive NF-κB activity and reduces tumor burden in a canine model of relapsed, refractory diffuse large B-cell lymphoma.

Anita Gaurnier-Hausser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.